NCT06834230View on ClinicalTrials.gov

Effect of Dotinurad in Hyperuricemia With Hypertension

PHASE4RecruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

March 28, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

March 31, 2030

Conditions
Hyperuricemia or GoutHypertension
Interventions
DRUG

Dotinurad

Start at 0.5 mg once daily, and then referring to the attached document, gradually increase the dose to the maintenance dose (2 mg once daily).

DRUG

Febuxostat

Start at 10 mg once daily, and then referring to the attached document, gradually increase the dose to the maintenance dose (40 mg once daily).

Trial Locations (1)

849-8501

RECRUITING

Saga University Hospital, Saga

All Listed Sponsors
lead

Saga University

OTHER